Skip to Content

AHI 500 (Mycophenolate mofetil 500 mg)

Pill imprint AHI 500 has been identified as Mycophenolate mofetil 500 mg.

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; dermatomyositis; organ transplant, rejection prophylaxis; myasthenia gravis; autoimmune hepatitis (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 500 mg is not a controlled substance under the Controlled Substance Act (CSA).

Mycophenolate mofetil 500 mg AHI 500
Mycophenolate mofetil 500 mg AHI 500 Front
Mycophenolate mofetil 500 mg AHI 500 Back
Discount Card Promo
Mycophenolate mofetil
Imprint:
AHI 500
Strength:
500 mg
Color:
Purple
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Accord Healthcare

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide